Joshua Watson, MD
Internal Medicine · Mount Pleasant, SCNPI 1831171461
Payments from drug & device makers
Across 404 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- QOL Medical, LLC$916
- Johnson & Johnson$580
- Daiichi Sankyo Inc.$244
- Medtronic$214
- plus $2K from 29 others
What the payments were for
- Food & beverage$8,144100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 136 | $2,585 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 69 | $1,187 |
| QOL Medical, LLC | 34 | $916 |
| Johnson & Johnson(2 entities) | 32 | $580 |
| Daiichi Sankyo Inc. | 12 | $244 |
| Medtronic | 4 | $214 |
| Ironwood Pharmaceuticals, Inc | 11 | $179 |
| Bristol Myers Squibb | 9 | $169 |
| Pfizer | 8 | $150 |
| Madrigal Pharmaceuticals | 7 | $147 |
| Ferring Pharmaceuticals Inc. | 9 | $142 |
| Merck | 9 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $135 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| Lucid Diagnostics Inc. | 2 | $114 |
| Ardelyx, Inc. | 4 | $109 |
| Sanofi | 4 | $94 |
| Celltrion USA Inc. | 5 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| Intercept Pharmaceuticals, Inc. | 5 | $81 |
| Lilly USA, LLC | 4 | $81 |
| Redhill Biopharma Inc. | 4 | $81 |
| Braintree Laboratories, Inc. | 4 | $73 |
| Nestle Healthcare Nutrition Inc. | 3 | $70 |
| Aimmune Therapeutics, Inc. | 3 | $67 |
| Boston Scientific | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Neuraxis, Inc. | 1 | $37 |
| E.r. Squibb & Sons, L.L.C. | 1 | $29 |
| Alfasigma USA, Inc. | 2 | $27 |
| Romark Laboratories, LC | 1 | $25 |
| Axonics, Inc. | 2 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Gilead | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,151 in reported general payments places this provider in the 90th percentile of 1,498 internal medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 31 | $101,015 |
| Humira PenAdalimumab | 12 | $80,048 |
| LinzessLinaclotide | 16 | $15,229 |
| VoqueznaVonoprazan Fumarate | 11 | $11,239 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 53 | $8,544 |
| Mesalamine | 19 | $4,765 |
| Colesevelam Hcl | 19 | $1,670 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 25 | $1,354 |
| Colestipol Hcl | 15 | $1,087 |
| Pantoprazole Sodium | 75 | $925 |
| Omeprazole | 53 | $815 |
| Esomeprazole Magnesium | 15 | $718 |
| Ondansetron OdtOndansetron | 14 | $473 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $2,585 | $116,24447 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $48 | $11,23911 claims |
| Braintree Laboratories, Inc.Sutab | $73 | $8,54453 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Mount Pleasant
- Yvonne DavisMount Pleasant$2.4M
- Rica SantiagoMt Pleasant$10.7M
- Richard MillsMt Pleasant$5.5M
- David BolsterSummerville$2.3M
- Colby GrossmanSummerville$1.4M
- Amit ShahIndian Land$1.4M
- Philip NicolMurrells Inlet$782K
- Carl SofleyAnderson$673K
- Carl MitchellColumbia$564K
- Jerry BackNorth Charleston$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.